Prophylactic effects of duloxetine on post-stroke depression symptoms: An open single-blind trial

European Neurology

Volumn 69, Issue 6, 2013, Pages 336-343

  Zhang, Li San ^a,b   Hu, Xing Yue ^a   Yao, Lin Yan ^a   Geng, Yu ^a   Wei, Li Li ^a   Zhang, Jin Hua ^a   Chen, Wei ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Duloxetine; Post stroke depression; Quality of life; Rehabilitation

Indexed keywords

ACETYLSALICYLIC ACID; DULOXETINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACTIVITIES OF DAILY LIVING SCALE; ADULT; BRAIN ISCHEMIA; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; NATIONAL INSTITUTE OF STROKE SCALE; POST STROKE DEPRESSION; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REHABILITATION CARE; REVIEW; SHORT FORM 36; SINGLE BLIND PROCEDURE; STROKE PATIENT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; HAMILTON DEPRESSION RATING SCALE; INCIDENCE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; POSTSTROKE DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYMPTOMATOLOGY; TREATMENT DURATION;

AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SINGLE-BLIND METHOD; STROKE; THIOPHENES;

EID: 84875661737     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000345374     Document Type: Review

References (42)

1. Thom T, Haase N, Rosamond W, et al: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151.
2. Ferri CP, Schoenborn C, Kalra L, et al: Prevalence of stroke and related burden among older people living in Latin America, India and China. J Neurol Neurosurg Psychiatry 2011; 82: 1075-1082.
3. Gainotti G, Antonucci G, Marra C, Paolucci S: Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001; 71: 258-261. (Pubitemid 32675158)
4. Paolucci S, Gandolfo C, Provinciali L, et al: Quantification of the risk of post-stroke depression: the Italian multicenter observational study DESTRO. Acta Psychiatr Scand 2005; 112: 272-278. (Pubitemid 41382733)
5. Caeiro L, Ferro JM, Santos CO, Figueira ML: Depression in acute stroke. J Psychiatry Neurosci 2006; 31: 377-383. (Pubitemid 44807897)
6. Chau JP, Thompson DR, Chang AM, et al: Depression among Chinese stroke survivors six months after discharge from a rehabilitation hospital. J Clin Nurs 2010; 19: 3042-3050.
7. Ferro JM, Caeiro L, Santos C: Poststroke emotional and behavior impairment: a narrative review. Cerebrovasc Dis 2009; 27(suppl 1):197-203.
8. Linden T, Blomstrand C, Skoog I: Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke 2007; 38: 1860-1863. (Pubitemid 46847260)
9. Hadidi N, Treat-Jacobson DJ, Lindquist R: Poststroke depression and functional outcome: a critical review of literature. Heart Lung 2009; 38: 151-162.
10. Williams LS: Depression and stroke: cause or consequence. Semin Neurol 2005; 25: 396-409.
11. Rush AJ, Trivedi MH, Wisniewski SR, et al: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR * D report. Am J Psychiatry 2006; 163: 1905-1917. (Pubitemid 44807782)
12. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR: Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993; 150: 124-129. (Pubitemid 23059176)
13. Robinson RG, Jorge RE, Clarence-Smith K, Starkstein S: Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci 2009; 21: 144-151.
14. Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS: Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006; 37: 156-161. (Pubitemid 43732065)
15. Paolucci S, Antonucci G, Grasso MG, et al: Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 2001; 12: 264-271. (Pubitemid 32973960)
16. Gabaldon L, Fuentes B, Frank-Garcia A, Díez-Tejedor E: Poststroke depression: importance of its detection and treatment. Cerebrovasc Dis 2007; 24(suppl 1):181-188. (Pubitemid 350035865)
17. Mohr P, Bitter I, Svestka J, et al: Management of depression in the presence of pain symptoms. Psychiatr Danub 2010; 22: 4-13.
18. Ellekjaer H, Holmen J, Indredavik B, Terent A: Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke 1997; 28: 2180-2184. (Pubitemid 27497919)
19. Chen P, Yu ES, Zhang M, Liu WT, Hill R, Katzman R: ADL dependence and medical conditions in Chinese older persons: a population-based survey in Shanghai, China. J Am Geriatr Soc 1995; 43: 378-383.
20. Appelros P, Terent A: Characteristics of the National Institute of Health Stroke Scale: results from a population-based stroke cohort at baseline and after one year. Cerebrovasc Dis 2004; 17: 21-27. (Pubitemid 38145904)
21. Fleck MP, Poirier-Littre MF, Guelfi JD, Bourdel MC, Loo H: Factorial structure of the 17-item Hamilton Depression Rating Scale. Acta Psychiatr Scand 1995; 92: 168-172.
22. Cockrell JR, Folstein MF: Mini-Mental State Examination (MMSE). Psychopharmacol Bull 1988; 24: 689-692.
23. Anderson C, Laubscher S, Burns R: Validation of the Short Form 36 (SF-36) Health Survey Questionnaire among stroke patients. Stroke 1996; 27: 1812-1816. (Pubitemid 26332511)
24. Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients. A 3-year longitudinal study. Stroke 1993; 24: 976-982. (Pubitemid 23201453)
25. Morrison V, Pollard B, Johnston M, Mac-Walter R: Anxiety and depression 3 years following stroke: demographic, clinical, and psychological predictors. J Psychosom Res 2005; 59: 209-213. (Pubitemid 41436570)
26. Trajkovic G, Starcevic V, Latas M, et al: Reliability of the Hamilton Rating Scale for Depression: a meta-analysis over a period of 49 years. Psychiatry Res 2011; 189: 1-9
27. Zheng YP, Zhao JP, Phillips M, et al: Validity and reliability of the Chinese Hamilton Depression Rating Scale. Br J Psychiatry 1988; 152: 660-664.
28. Cheung RT, Lyden PD, Tsoi TH, et al: Production and validation of Putonghua-and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videos. Int J Stroke 2010; 5: 74-79.
29. Ravaglia G, Forti P, Maioli F, et al: Screening for mild cognitive impairment in elderly ambulatory patients with cognitive complaints. Aging Clin Exp Res 2005; 17: 374-379. (Pubitemid 46179360)
30. Srinivasan S: The concise cognitive test for dementia screening: reliability and effects of demographic variables as compared to the mini mental state examination. Neurol India 2010; 58: 702-707.
31. Zhang M, Zhu Z, Chen P: Community investigation of the activities of daily living (ADL) and medical conditions of the elderly in Shanghai (in Chinese). Zhonghua Yi Xue Za Zhi 1998; 78: 124-127.
32. Koh ET, Leong KP, Tsou IY, et al: The reliability, validity and sensitivity to change of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 1023-1028. (Pubitemid 44283061)
33. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P: A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003; 44: 216-221. (Pubitemid 36514728)
34. Robinson RG, Jorge RE, Moser DJ, et al: Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008; 299: 2391-2400. (Pubitemid 351749237)
35. Almeida OP, Waterreus A, Hankey GJ: Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 2006; 67: 1104-1109. (Pubitemid 44230882)
36. Dolder C, Nelson M, Stump A: Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients. Drugs Aging 2010; 27: 625-640.
37. Girardi P, Pompili M, Innamorati M, et al: Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol 2009; 24: 177-190.
38. Gabaldon L, Fuentes B, Frank-Garcia A, Díez-Tejedor E: Poststroke depression: importance of its detection and treatment. Cerebrovasc Dis 2007; 24(suppl 1):181-188. (Pubitemid 350035865)
39. Fava M, Martinez JM, Greist J, et al: The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study. Ann Clin Psychiatry 2007; 19: 187-195. (Pubitemid 47345874)
40. Schmid AA, Kroenke K, Hendrie HC, Bakas T, Sutherland JM, Williams LS: Poststroke depression and treatment effects on functional outcomes. Neurology 2011; 76: 1000-1005.
41. Guidotti G, Calabrese F, Auletta F, et al: Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment. Neuropsychopharmacology 2012; 37: 746-758.
42. Calabrese F, Molteni R, Maj PF, et al: Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 2007; 32: 2351-2359. (Pubitemid 47587673)